AMICUS THERAPEUTICS INC
Net BuyingFOLD·US·🇺🇸 US
87%buys·13%sales
9,703 transactions$379.1MTotal buys·6,653 buys
$384.4MTotal sells·1,036 sells
9797 insiders
Last: Dec 26, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 26, 25 | Harford Simon N.R. | Other | $1.0M | |
| Dec 26, 25 | Campbell Bradley L | Other | $1.5M | |
| Dec 19, 25 | Clark David Michael | Sell | $363K | |
| Dec 15, 25 | Campbell Bradley L | Exercise | - | |
| Dec 15, 25 | Clark David Michael | Sell | $282K | |
| Dec 15, 25 | Campbell Bradley L | Sell | $846K | |
| Dec 15, 25 | Campbell Bradley L | Exercise | $636K | |
| Dec 1, 25 | Campbell Bradley L | Exercise | - | |
| Dec 1, 25 | Prout Samantha | Grant | - | |
| Dec 1, 25 | Campbell Bradley L | Sell | $146K |
Campbell Bradley L (CEO) recently executed a sell of $846K in AMICUS THERAPEUTICS INC shares on December 15, 2025. Overall insider sentiment is bullish (87% purchases).
AMICUS THERAPEUTICS INC (FOLD) has recorded 9 703 insider operations, including 6 653 open-market purchases ($379.1M), 1 036 sales ($384.4M) and 2 014 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (87% purchases).
AMICUS THERAPEUTICS INC shows moderate insider activity with 7 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Crowley John F (CEO), Campbell Bradley L (CEO) & Patterson Matthew R (CEO), with respectively 652, 359, 197 transactions.
Across all 9 703 recorded transactions, the breakdown by type is: buys (6653, 69%), exercise (1125, 12%), sales (1036, 11%), grant (619, 6%), tax (232, 2%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
AMICUS THERAPEUTICS INC has recorded 9 703 insider operations in total, including 6 653 open-market purchases ($379.1M), 1 036 sales ($384.4M) and 2 014 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 26, 2025.
Insiders at AMICUS THERAPEUTICS INC are currently net buyers, with 87% purchases and 13% sales across all reported transactions. Total buy volume is $379.1M versus $384.4M in sales, indicating a bullish insider sentiment.
InsiderLens tracks 97 insiders at AMICUS THERAPEUTICS INC (FOLD). Crowley John F (CEO, 652 tx), Campbell Bradley L (CEO, 359 tx), Patterson Matthew R (CEO, 197 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for FOLD is bullish, based on a 87% buy ratio across 7 689 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for AMICUS THERAPEUTICS INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.